Literature DB >> 4306720

Substiuted sialic acid prosthetic groups as determinants of viral hemagglutination.

B Levinson, D Pepper, G Belyavin.   

Abstract

Inhibitors of hemagglutination by type A2 influenza virus and a recently isolated strain of type B influenza virus were separated by sucrose density gradient centrifugation and agarose gel filtration from horse serum. Using selected reagents, it was demonstrated that the active substituent on the horse serum inhibitor of A2 influenza virus was 4-O-acetyl-N-acetylneuraminic acid; however, the active substituent on the inhibitor of the influenza B virus was shown to be N-acetylneuraminic acid (NANA). Sodium metaperiodate treatment of a component of horse serum resulted in a 10 to 15-fold enhancement of inhibitory activity against the type B virus, whereas the A2 inhibitor was completely destroyed. Since this enhancement did not occur with influenza B viruses isolated prior to 1965, it was considered that this sensitivity to an oxidized NANA glycoside may have been a reflection of an antigenic change which occurred at that time. The use of different virus strains and selected chemical reagents to define the important sialic acid prosthetic groups active in inhibition was described.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4306720      PMCID: PMC375797     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  Influenza complement-fixation; a simple quantitative micro-method.

Authors:  G BELYAVIN
Journal:  J Hyg (Lond)       Date:  1953-12

3.  Properties of horse serum gamma inhibitor.

Authors:  F Biddle; D S Pepper; G Belyavin
Journal:  Nature       Date:  1965-07-24       Impact factor: 49.962

4.  [Action specificity of neuraminidase. The action of bacterial neuraminidase on isomeric N,O-diacetylneuraminic acid glycosides in the submaxilllary mucin of horse and cow].

Authors:  R Schauer; H Faillard
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1968-08

5.  The isolation and properties of gamma inhibitor: an equine alpha 2-macroglobulin sub-fraction.

Authors:  D S Pepper
Journal:  Biochim Biophys Acta       Date:  1968-03-11

6.  The sialic acids of horse serum with special reference to their virus inhibitory properties.

Authors:  D S Pepper
Journal:  Biochim Biophys Acta       Date:  1968-03-11

7.  Influenza B in the spring of 1965.

Authors:  C C Mascoli; M B Leagus; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1966-12

8.  A chromatographic procedure for the purification of influenza virus.

Authors:  D S Pepper
Journal:  J Gen Virol       Date:  1967-01       Impact factor: 3.891

9.  Automatic technique for titration of influenza virus haemagglutination inhibitors.

Authors:  A Cohen
Journal:  J Clin Pathol       Date:  1966-11       Impact factor: 3.411

10.  A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses.

Authors:  I TAMM; F L HORSFALL
Journal:  J Exp Med       Date:  1952-01       Impact factor: 14.307

View more
  10 in total

1.  The occurrence of human influenza virus antibodies in the sera of certain wild species of animal. Brief report.

Authors:  K F Shortridge; G Belyavin; D E Bidwell
Journal:  Arch Gesamte Virusforsch       Date:  1970

2.  Human placental alkaline phosphatase, an inhibitor of hemagglutination by PR8-influenza A virus.

Authors:  N K Ghosh; A Rukenstein; C Labowsky; R P Cox
Journal:  Experientia       Date:  1974-04-15

3.  Identification of a Novel Inhibitor of Human Rhinovirus Replication and Inflammation in Airway Epithelial Cells.

Authors:  Zhonghui Yang; Yury A Bochkov; Dennis R Voelker; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

4.  Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins.

Authors:  E M Anders; C A Hartley; D C Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs.

Authors:  James Stevens; Li-Mei Chen; Paul J Carney; Rebecca Garten; Angie Foust; Jianhua Le; Barbara A Pokorny; Ramanunninair Manojkumar; Jeanmarie Silverman; Rene Devis; Karen Rhea; Xiyan Xu; Doris J Bucher; James C Paulson; James Paulson; Nancy J Cox; Alexander Klimov; Ruben O Donis
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

6.  Effective one-pot multienzyme (OPME) synthesis of monotreme milk oligosaccharides and other sialosides containing 4-O-acetyl sialic acid.

Authors:  Hai Yu; Jie Zeng; Yanhong Li; Vireak Thon; Baojun Shi; Xi Chen
Journal:  Org Biomol Chem       Date:  2016-08-22       Impact factor: 3.876

Review 7.  Virus-erythrocyte interactions.

Authors:  C Howe; L T Lee
Journal:  Adv Virus Res       Date:  1972       Impact factor: 9.937

Review 8.  Glycan microarray technologies: tools to survey host specificity of influenza viruses.

Authors:  James Stevens; Ola Blixt; James C Paulson; Ian A Wilson
Journal:  Nat Rev Microbiol       Date:  2006-10-02       Impact factor: 60.633

9.  Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host.

Authors:  M Matrosovich; P Gao; Y Kawaoka
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Distribution of O-Acetylated Sialic Acids among Target Host Tissues for Influenza Virus.

Authors:  Brian R Wasik; Karen N Barnard; Robert J Ossiboff; Zahra Khedri; Kurtis H Feng; Hai Yu; Xi Chen; Daniel R Perez; Ajit Varki; Colin R Parrish
Journal:  mSphere       Date:  2017-09-06       Impact factor: 4.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.